amsterdam : DSM

April 08, 2013 12:29 ET

DSM and Rostekhnologii to cooperate on biotechnology and functional materials

HEERLEN, NETHERLANDS--(Marketwired - Apr 8, 2013) -

Royal DSM, the global Life Sciences and Materials Sciences company, announces today that it has signed a Memorandum of Understanding (MOU) for a strategic partnership with Rostekhnologii (Rostec), a Russian State Corporation, in the fields of biotechnology and functional materials. The MOU was signed today in Amsterdam (Netherlands) in the presence of President Vladimir Putin of the Russian Federation and Prime Minister Mark Rutte of the Netherlands.

Under the terms of the MOU, DSM and Rostec will explore a potential cooperation in the field of conversion of cellulosic biomass from forestry and agriculture to fermentable sugars for the production of biofuels and/or biobased chemicals as well as the manufacturing of bio-based products such as bioethanol, biogas and organic acids from sugars derived from cellulosic biomass.

DSM and Rostec will also explore to cooperate in the area of enhancing the performance of Russia's fast expanding optical fiber networks using DSM's UV- curable resins optical fiber materials. In addition, DSM Dyneema and RT- Chemcomposite, part of Rostec, will investigate the establishment of a joint venture for the production and sales of Uni-Directional products based on Ultra High Molecular Weight PE-fibers in Russia using DSM's proprietary technology for life protection applications.

Vladimir Artyakov, Deputy CEO of Rostekhnologii, said: "The cooperation with DSM will accelerate the process of introducing new, unique products in the Russian market to be used in different areas, including biotechnology and functional materials. The partnership with DSM is strategic and intended for the long term."

Feike Sijbesma, Chief Executive Officer and Chairman of the DSM Managing Board, said: "As 2013 was declared a year of friendship between the Netherlands and Russia, this is a perfect occasion to explore opportunities for further cooperation between DSM and Russia. With two joint ventures already in place, I am looking forward to a successful cooperation in several important business areas including the development of advanced biofuels with Rostec."

For DSM, Russia is one of the High Growth Economies the company is focusing on in executing its strategy DSM in motion: driving focused growth. DSM's main business areas in Russia are food and feed ingredients, pharmaceutical intermediate products, biotechnology, fiber materials, resins and engineering plastics. Through its business activities, DSM meets the needs and trends in the Russian Federation, including localization (import substitution), modernization in technologies and diversification (less oil dependence). In 2012, DSM celebrated 20 years of presence in Russia.

In 2010 DSM started a joint venture in Tatarstan to contribute to Russia's goal of reaching a higher self-sufficiency in animal protein production and supply by securing better animal nutrition. In 2011 DSM entered into a long-term partnership in the area of engineering plastics with JSC KuibyshevAzot in Tolyatti (Samara Region) in order to supply locally produced products to the automotive and electrical & electronics industries.


State Corporation Russian Technologies (Rostec) is a Russian corporation established in 2007 in order to facilitate the development, manufacturing and export of high-technology industrial products. Today it comprises about 663 companies with activities ranging from automotive to aviation, building, electronics, telecommunications and defense technology. Rostec's subsidiaries are located in 60 regions of the Russian Federation and supply their products to over 70 countries worldwide. In 2012 net sales amounted to RUB 963 billion (~EUR 24 billion) with more than 900,000 employees.

DSM - Bright Science. Brighter Living.™

Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 23,500 employees deliver annual net sales of around EUR9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.

Press release-pdf: http://hugin.info/130663/R/1691212/555338.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: DSM N.V. via Thomson Reuters ONE


Contact Information

  • For more information:
    DSM Corporate Communications
    Herman Betten
    tel. +31 (0) 45 5782017
    e-mail Email Contact

    DSM Investor Relations
    Dave Huizing
    tel. +31 (0) 45 5782864
    e-mail Email Contact

    Antonina Gribanova
    Tel. +7 (967) 053 85 68
    e-mail Email Contact

    Yulia Lebedinskaya
    Tel. +7 (967) 053 72 15
    e-mail Email Contact